Displaying 1 - 20 of 1467
FTC Files Amicus Brief in Sage Chemical vs. Supernus Pharmaceutical Supporting Competition in the Market for Drug Used to Treat Advanced Parkinson’s Disease
FTC and Justice Department to Hold Annual Spring Enforcers Summit
Intercontinental Exchange, Inc./Black Knight, Inc., In the Matter of
Microsoft/Activision Blizzard, In the Matter of
The Federal Trade Commission authorized an administrative complaint against the proposed merger between Microsoft Corp. and Activision Blizzard, Inc., a video game developer that creates and publishes games such as Call of Duty, World of Warcraft, Diablo, and Overwatch. Microsoft sells the Xbox gaming console and also offers a video game subscription service called Xbox Game Pass, as well as a cloud-based video game streaming service. The agency alleges that the deal would enable Microsoft to suppress competitors to its Xbox gaming consoles and its rapidly growing subscription and cloud-gaming business. An evidentiary hearing is scheduled for Aug. 2, 2023 at 10 a.m. ET before an Administrative Law Judge at the FTC’s headquarters at 600 Pennsylvania Ave. N.W., Room 532.
FTC Acts to Block Deal Combining the Two Top Mortgage Loan Technology Providers
Illumina, Inc., and GRAIL, Inc., In the Matter of
The Federal Trade Commission filed an administrative complaint and authorized a federal court lawsuit to block Illumina’s $7.1 billion proposed acquisition of Grail—a maker of a non-invasive, early detection liquid biopsy test that can screen for multiple types of cancer in asymptomatic patients at very early stages using DNA sequencing. Illumina is the only provider of DNA sequencing that is a viable option for these multi-cancer early detection, or MCED, tests in the United States.
The complaint alleges the proposed acquisition will diminish innovation in the U.S. market for MCED tests, which could be used to detect up to 50 types of cancer. Most of these types of cancer are not screened for at all today, and the MCED test could save millions of lives around the world. The trial began on Aug. 24, 2021. On May 20, 2021, the FTC authorized staff to dismiss its federal court complaint for Preliminary Injunction and Temporary Restraining Order.
Altria Group/JUUL Labs, In the Matter of
The Federal Trade Commission filed an administrative complaint alleging that Altria Group, Inc. and JUUL Labs, Inc. entered a series of agreements, including Altria’s acquisition of a 35% stake in JUUL, that eliminated competition in violation of federal antitrust laws. According to the complaint, this series of agreements involved Altria ceasing to compete in the U.S. market for closed-system electronic cigarettes in return for a substantial ownership interest in JUUL, by far the dominant player in that market. In an initial decision announced on Feb. 24, 2022, Chief Administrative Law Judge D. Michael Chappell dismissed the antitrust charges in the complaint.
Joint Statement of Chair Khan, Commissioner Slaughter, Commissioner Wilson, and Commissioner Bedoya, Regarding Amazon.com, Inc.'s Acquisition of 1Life Healthcare, Inc.
Statement of Commissioner Alvaro M. Bedoya Joined by Commissioner Rebecca Kelly Slaughter Regarding Amazon.com, Inc.'s Acquisition of 1Life Healthcare, Inc.
Statement of Elizabeth Wilkins, Director of the FTC’s Office of Policy Planning, on the Decision of SUNY Upstate Medical University and Crouse Health System, Inc. to Drop Their Proposed Merger
Statement of Commissioner Rebecca Kelly Slaughter, Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya, Regarding the FY2021 HSR Annual Report
FTC, DOJ Issue Fiscal Year 2021 Hart Scott Rodino Premerger Notification Report
Statement of Commissioner Christine S. Wilson Regarding the FY2021 HSR Annual Report
Remarks by Holly Vedova at 12th Annual GCR Live: Law Leaders Global Conference
Dissenting Statement of Commissioner Christine S. Wilson Regarding the Petition for Recusal of Chair Lina M. Khan from Involvement in the Matter of Meta/Zuckerberg/Within
FTC Announces 2023 Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates
Premerger Notification; Reporting and Waiting Period Requirements for 2023
Revised Jurisdictional Thresholds for Section 8 of the Clayton Act for 2023
Displaying 1 - 20 of 1467